Literature DB >> 31474492

Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study.

Michaela R Anderson1, Jayaram K Udupa2, Ethan Edwin3, Joshua M Diamond4, Jonathan P Singer5, Jasleen Kukreja6, Steven R Hays5, John R Greenland5, Anthony Ferrante3, Matthew Lippel1, Tatiana Blue1, Amika McBurnie1, Michelle Oyster4, Laurel Kalman4, Melanie Rushefski4, Caiyun Wu2, Gargi Pednekar2, Wen Liu1, Selim Arcasoy1, Joshua Sonett7, Frank D'Ovidio7, Matthew Bacchetta8, John D Newell9, Drew Torigian2, Edward Cantu10, Donna L Farber11, Jon T Giles1, Yubing Tong2, Scott Palmer12, Lorraine B Ware13, Wayne W Hancock14, Jason D Christie4, David J Lederer15.   

Abstract

BACKGROUND: Obesity is associated with an increased risk of primary graft dysfunction (PGD) after lung transplantation. The contribution of specific adipose tissue depots is unknown.
METHODS: We performed a prospective cohort study of adult lung transplant recipients at 4 U.S. transplant centers. We measured cross-sectional areas of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) on chest and abdominal computed tomography (CT) scans and indexed each measurement to height.2 We used logistic regression to examine the associations of adipose indices and adipose classes with grade 3 PGD at 48 or 72 hours, and Cox proportional hazards models to examine survival. We used latent class analyses to identify the patterns of adipose distribution. We examined the associations of adipose indices with plasma biomarkers of obesity and PGD.
RESULTS: A total of 262 and 117 subjects had available chest CT scans and underwent protocol abdominal CT scans, respectively. In the adjusted models, a greater abdominal SAT index was associated with an increased risk of PGD (odds ratio 1.9, 95% CI 1.02-3.4, p = 0.04) but not with survival time. VAT indices were not associated with PGD risk or survival time. A greater abdominal SAT index correlated with greater pre- and post-transplant leptin (r = 0.61, p < 0.001, and r = 0.44, p < 0.001), pre-transplant IL-1RA (r = 0.25, p = 0.04), and post-transplant ICAM-1 (r = 0.25, p = 0.04). We identified 3 latent patterns of adiposity. The class defined by high thoracic and abdominal SAT had the greatest risk of PGD.
CONCLUSIONS: Subcutaneous, but not visceral, adiposity is associated with an increased risk of PGD after lung transplantation.
Copyright © 2019 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adipose tissue; inflammation; lung transplantation; obesity; primary graft dysfunction

Year:  2019        PMID: 31474492      PMCID: PMC6883162          DOI: 10.1016/j.healun.2019.08.013

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  63 in total

1.  Obesity is associated with neutrophil dysfunction and attenuation of murine acute lung injury.

Authors:  Lauren L Kordonowy; Elianne Burg; Christopher C Lenox; Lauren M Gauthier; Joseph M Petty; Maryellen Antkowiak; Tatsiana Palvinskaya; Niki Ubags; Mercedes Rincón; Anne E Dixon; Juanita H J Vernooy; Michael B Fessler; Matthew E Poynter; Benjamin T Suratt
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-15       Impact factor: 6.914

2.  Optimization of abdominal fat quantification on CT imaging through use of standardized anatomic space: a novel approach.

Authors:  Yubing Tong; Jayaram K Udupa; Drew A Torigian
Journal:  Med Phys       Date:  2014-06       Impact factor: 4.071

3.  Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.

Authors:  Joshua M Diamond; Nuala J Meyer; Rui Feng; Melanie Rushefski; David J Lederer; Steven M Kawut; James C Lee; Edward Cantu; Rupal J Shah; Vibha N Lama; Sangeeta Bhorade; Maria Crespo; Ejigayehu Demissie; Joshua Sonett; Keith Wille; Jonathan Orens; Ann Weinacker; David Weill; Selim Arcasoy; Pali D Shah; John A Belperio; David Wilkes; Lorraine B Ware; Scott M Palmer; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2012-07-19       Impact factor: 21.405

4.  Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils.

Authors:  J D Langereis; E-J D Oudijk; R C Schweizer; J-W J Lammers; L Koenderman; L H Ulfman
Journal:  Eur Respir J       Date:  2010-07-22       Impact factor: 16.671

5.  Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

Authors:  David J Lederer; Steven M Kawut; Nancy Wickersham; Christopher Winterbottom; Sangeeta Bhorade; Scott M Palmer; James Lee; Joshua M Diamond; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria Crespo; Jonathan B Orens; Joshua R Sonett; Selim M Arcasoy; Lorraine B Ware; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

6.  Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.

Authors:  Shiraz A Daud; Roger D Yusen; Bryan F Meyers; Murali M Chakinala; Michael J Walter; Aviva A Aloush; G Alexander Patterson; Elbert P Trulock; Ramsey R Hachem
Journal:  Am J Respir Crit Care Med       Date:  2006-12-07       Impact factor: 21.405

7.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Abdominal obesity is an independent risk factor for chronic heart failure in older people.

Authors:  Barbara J Nicklas; Matteo Cesari; Brenda W J H Penninx; Stephen B Kritchevsky; Jingzhong Ding; Anne Newman; Dalane W Kitzman; Alka M Kanaya; Marco Pahor; Tamara B Harris
Journal:  J Am Geriatr Soc       Date:  2006-03       Impact factor: 5.562

9.  Bone marrow leptin signaling mediates obesity-associated adipose tissue inflammation in male mice.

Authors:  Lea H Dib; M Teresa Ortega; Sherry D Fleming; Stephen K Chapes; Tonatiuh Melgarejo
Journal:  Endocrinology       Date:  2013-12-20       Impact factor: 4.736

10.  Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.

Authors:  T Gainsford; T A Willson; D Metcalf; E Handman; C McFarlane; A Ng; N A Nicola; W S Alexander; D J Hilton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

View more
  6 in total

1.  Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition Study.

Authors:  Nadine Al-Naamani; Hao-Min Pan; Michaela R Anderson; Drew A Torigian; Yubing Tong; Michelle Oyster; Mary K Porteous; Scott Palmer; Selim M Arcasoy; Joshua M Diamond; Jayaram K Udupa; Jason D Christie; David J Lederer; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2020-11

2.  Adiposity and Interstitial Lung Abnormalities in Community-Dwelling Adults: The MESA Cohort Study.

Authors:  Michaela R Anderson; John S Kim; Matthew Allison; Jon T Giles; Eric A Hoffman; Jingzhong Ding; R Graham Barr; Anna Podolanczuk
Journal:  Chest       Date:  2021-04-15       Impact factor: 10.262

3.  Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation.

Authors:  Karolina Grąt; Ryszard Pacho; Michał Grąt; Marek Krawczyk; Krzysztof Zieniewicz; Olgierd Rowiński
Journal:  J Clin Med       Date:  2019-10-13       Impact factor: 4.241

Review 4.  Primary graft dysfunction: what we know.

Authors:  Emily Clausen; Edward Cantu
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 3.005

Review 5.  Anesthetic considerations in lung transplantation: past, present and future.

Authors:  Andrew W Murray; Michael L Boisen; Ashley Fritz; J Ross Renew; Archer Kilbourne Martin
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

6.  Obesity-related IL-18 Impairs T-Regulatory Cell Function and Promotes Lung Ischemia-Reperfusion Injury.

Authors:  Tatiana Akimova; Tianyi Zhang; Lanette M Christensen; Zhonglin Wang; Rongxiang Han; Dmitry Negorev; Arabinda Samanta; Isaac E Sasson; Trivikram Gaddapara; Jing Jiao; Liqing Wang; Tricia R Bhatti; Matthew H Levine; Joshua M Diamond; Ulf H Beier; Rebecca A Simmons; Edward Cantu; David S Wilkes; David J Lederer; Michaela Anderson; Jason D Christie; Wayne W Hancock
Journal:  Am J Respir Crit Care Med       Date:  2021-11-01       Impact factor: 21.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.